Abstract
The beneficial effects of spironolactone on the treatment of cardiovascular diseases are well known, but translating these benefits into private practice can be difficult because of the drug's side-effect profile. When patients are monitored over the long term, spironolactone can be used safely with an acceptable side-effect profile. We retrospectively studied 762 patients taking spironolactone over a 7-year period in a cardiologist's referral-based practice and monitored them for side effects from the medication. Data were available on 762 patients. The average age of our patients when started on the medication was 67.2 +/- 0.5 years. Of these, 585 (76.8%) patients were treated for heart failure and 155 (20.3%) for hypertension. An average dose of 38.4 +/- 1.4 mg of spironolactone was used for treatment of all conditions. Of the 762 patients, 81 (10.6%) experienced side effects while using the medication; 40 had hyperkalemia (5.3%), 14 had gynecomastia (1.8%), and 15 had gastritis (2%). Of the patients with hyperkalemia, average creatinine clearance decreased from 64.6 +/- 5.8 ml/min at therapy start to 50.3 +/- 5.5 ml/min at the time of onset of side effects. Spironolactone can be used with an acceptable side-effect profile a...Continue Reading
References
Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Nov 1, 1990·Circulation·K SwedbergL Wilhelmsen
Dec 1, 1981·The Journal of Endocrinology·J StaessenA Amery
Sep 2, 1999·The New England Journal of Medicine·B PittJ Wittes
Feb 15, 2000·Circulation·C A Farquharson, A D Struthers
May 10, 2000·The American Journal of Cardiology·F J RamiresJ A Ramires
Nov 30, 2000·Circulation·F ZannadB Pitt
May 2, 2001·The American Journal of Medicine·H SchepkensN Lameire
Jan 5, 2002·The New England Journal of Medicine·K T Weber
Jul 11, 2002·Journal of the American College of Cardiology·Mariantonietta CicoiraPiero Zardini
Jan 22, 2003·Journal of the American College of Cardiology·Biykem BozkurtA A Knowlton
Jan 22, 2003·Journal of the American College of Cardiology·W H Wilson Tang, Gary S Francis
Feb 25, 2003·Journal of the American College of Cardiology·Shu KasamaMasahiko Kurabayashi
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
May 21, 2003·Circulation·Nancy J Brown
Aug 6, 2004·The New England Journal of Medicine·David N JuurlinkDonald A Redelmeier
Citations
Apr 29, 2010·Current Hypertension Reports·Richard E KatholiPaul A Sobotka
Dec 28, 2016·Journal of Pain and Symptom Management·Laura CaroneAndrew Wilcock
Mar 11, 2008·Pharmacoepidemiology and Drug Safety·Antonio RussoLuigi Bisanti
Mar 7, 2019·European Heart Journal Supplements : Journal of the European Society of Cardiology·Faiez ZannadBertram Pitt
Aug 1, 2020·Journal of Human Hypertension·Morag J YoungJun Yang
Jun 6, 2017·European Journal of Heart Failure·João Pedro FerreiraFaiez Zannad
Jun 8, 2021·Frontiers in Oncology·José A Carlos-EscalanteTalia Wegman-Ostrosky
Jul 7, 2021·Journal of the American Heart Association·Tobias SchuppMichael Behnes